COVIDS
Preferred Sample Type
Suitable Specimen Types
- Serum
3ml
Specimen Transport
Standard transport to laboratoryTurnaround Time
24 hrs from receiptSample Stability
7 days when stored at 4C or frozenSARS-Cov2 IgG Antibodies
General Information
This test is used to identify serological evidence of exposure to SARS-Cov2 , the virus that causes Covid-19 and or vaccine response
In an acute presentation this antibody test is likely to be negative with seroconversion occurring after 10-20 days. Sero conversion post vaccine is not expected to occur until after 15 days.
Notes
Overall specificity = 100%
Overall sensitivity = 90%
Please note that this assay is not currently included in
our ISO15189:2012 accreditation scope
Reference Range
SARS-CoV2 S1 Spike IgG reference range 0-49.9 AU/mL
Anti S1 IgG interpretation see below
Anti NC IgG interpretation see below
The test panel measures response to nucleocapsid (NC) and S1 spike proteins of SARS -COV2.
Current vaccines are based on the S1 spike protein only
Specifications
- EQA Scheme?: Yes No
- EQA Status: UK NEQAS for SARS COV-2/COVID 19 antibodies